Procedures marketed under the term “stem cell” can involve very different products depending on the cell source, preparation method and composition. A concentrate prepared from bone marrow or adipose tissue is not automatically the same as a purified stem-cell product.
Evidence in Orthopaedic Use
Research into cell-based products for musculoskeletal conditions is ongoing. Evidence, approval and legal status vary by product and condition. Reliable cartilage regeneration, halted osteoarthritis progression, meniscus repair or avoidance of surgery cannot be guaranteed. International regulators warn that many cellular products marketed for orthopaedic uses are not approved for those claims.
Decision-Making and Safety
Before any procedure is considered, patients should receive clear information about the product's exact name, source, preparation, regulatory status for the proposed use, expected benefit, uncertainties and alternatives. Preparation from the patient's own cells does not remove risk; infection, bleeding, unwanted immune or inflammatory responses, tissue injury and processing-related complications may occur.
This page provides general information only and does not recommend a procedure. Standard treatment should not be delayed; decisions must be made by an authorised physician and healthcare facility in line with current evidence and applicable regulations.